Novartis and Penn Unite On Anticancer Approach Digg this page for free send this page to a friend Add to your del.icio.us account

The alliance seeks to build on the results of an experimental treatment that trains a person's immune system to kill cancer cells.
User comments, Ratings and Reviews
News Reviews and Ratings
Be the first person to review this news article. By reviewing the news article you are automatically sent to our Online Sweepstakes and any questions on journal postings and more info from here
News Album Team,  Thursday, May 23, 2013 5:29:39 PM
Note: To write new journal then start here. The below is only to re-write the existing journal
Write your own Review on This News:

Required valid email. Confirmation sent here.
Not Much. 1 2 3 4 5 So Much......!

Human Verification Code     
Read more! [Bookmark & read later / Comment this story ]
Share this article:

You can Digg this article: Digg this page for free
Send Page to Friend(s):send this page to a friend
Bookmark with del.icio.us:Add to your del.icio.us account

Cast My Opinion

  

Article Taged as : novartis, penn, unite, anticancer, approach, http, feeds.nytimes.com, click.phdo, where, 22ffdbac83ac6921685d744ee895833d, novartis, penn, unite, anticancer, approach,

Article Statistics

Article Viewed 207 times.
Positive attitude 1 votes [0%]
Negetive attitude 1 votes [0%]

News Article Source & Groups

You can find this article under Business group. And brought to you by Channel New York Times, Find breaking news, multimedia, reviews
The XMl Feed Type text/xml;charset=UTF-8 and collected data 214560 bytes sized news and still counting.
Feed Server name is FeedsPortal and Code Page 65001 (UTF-8 Unicode)

New York Times: Business: Novartis and Penn Unite On Anticancer Approach
Date Listed : Monday, August 06, 2012
Source : NYT > Business, New York Times > Business

Related Stories
Home | Topics | Tell a Friend | Webmaster | Events | Subscribe | Link us | Submit News | My List